• Equity Capital Markets
  • Debt Capital Markets
  • Private Capital Advisory
  • Mergers & Acquisitions
  • Restructuring & Special Situations


  • Healthcare


Thomas McGlynn is a Director in the Healthcare & Life Sciences group with B. Riley Securities and has 11 years of experience advising companies on various public and private financings, mergers & acquisitions, and other strategic advisory mandates.

Prior to B. Riley, he held positions in investment banking at Deutsche Bank Securities, Macquarie Capital, and Cantor Fitzgerald, and in equity research at RBC Capital Markets.

Mr. McGlynn received a BBA with a concentration in Finance from Baruch College and an MBA from Columbia Business School. He is a CFA Charterholder.

B. Riley Securities is a leading middle market investment bank that provides a full suite of corporate finance, advisory, sales and trading and equity research. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary equity research.